Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Clinical Lung Cancer|January 17, 2004
Irinotecan (CPT-11) in triplet combinations in patients with advanced non small-cell lung cancer: a review and report of a phase I/II trialM A Socinski, A B Sandler, L L Miller, et al.
Bone Marrow Transplantation|August 1, 1991
Successful treatment of disseminated Fusarium infection after autologous bone marrow transplantation for acute myeloid leukemiaM J Robertson, M A Socinski, R J Soiffer, et al.
The Oncologist|February 22, 2001
Carboplatin/paclitaxel or carboplatin/vinorelbine followed by accelerated hyperfractionated conformal radiation therapy: a preliminary report of a phase I dose escalation trial from the Carolina Conformal Therapy ConsortiumM A Socinski, L B Marks, J Garst, et al.
Cancer|August 10, 2000
Induction carboplatin/paclitaxel followed by concurrent carboplatin/paclitaxel and dose-escalating conformal thoracic radiation therapy in unresectable stage IIIA/B nonsmall cell lung carcinoma: a modified Phase I trialM A Socinski, J G Rosenman, M J Schell, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 27, 2005
A randomized phase II trial comparing every 3-weeks carboplatin/paclitaxel with every 3-weeks carboplatin and weekly paclitaxel in advanced non-small cell lung cancerM A Socinski, A Ivanova, K Bakri, et al.
British Journal of Cancer|October 15, 2009
Phase II study of continuous daily sunitinib dosing in patients with previously treated advanced non-small cell lung cancerS Novello, G V Scagliotti, R Rosell, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 19, 2004
Combined modality trials of the Cancer and Leukemia Group B in stage III non-small-cell lung cancer: analysis of factors influencing survival and toxicityM A Socinski, C Zhang, J E Herndon, et al.
Cancer|September 26, 2001
Dose-escalating conformal thoracic radiation therapy with induction and concurrent carboplatin/paclitaxel in unresectable stage IIIA/B nonsmall cell lung carcinoma: a modified phase I/II trialM A Socinski, J G Rosenman, J Halle, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 28, 2015
Tecemotide in unresectable stage III non-small-cell lung cancer in the phase III START study: updated overall survival and biomarker analysesP Mitchell, N Thatcher, M A Socinski, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 17, 2009
A randomized, phase III multicenter trial of gemcitabine in combination with carboplatin or paclitaxel versus paclitaxel plus carboplatin in patients with advanced or metastatic non-small-cell lung cancerJ A Treat, R Gonin, M A Socinski, et al.
Pageof 6